Stock Region Penny Picks
Stock Region Watchlist Newsletter - Monday, June 30, 2025
Stock Region Penny Picks Watchlist Newsletter - Monday, June 30, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions. Stock Region is not responsible for any financial losses incurred.
Good morning, Stock Region family!
The market is buzzing with exciting updates, and we’re here to break it all down for you. From groundbreaking innovations to strategic moves, here’s what’s making waves today:
$LASE
Beamer Laser Marking Systems shines bright!
Beamer, a subsidiary of $LASE, just secured new orders for its T-Series and B-Series laser marking machines. These orders come from a top-tier contract manufacturer in Illinois and a leading international machining tools supplier in Michigan.
Our take: This is a solid win for $LASE, showcasing the growing demand for their cutting-edge laser marking technology. It’s always exciting to see companies like Beamer making strides in industrial innovation. Could this be a sign of more growth to come? Keep an eye on this one!
$WBUY
Crypto meets travel—what a combo!
$WBUY has integrated Coinbase Commerce into its platform, allowing customers to pay for travel packages and products using hundreds of cryptocurrencies, including USDC.
Our take: This is a bold and forward-thinking move by $WBUY. In a world where digital payments are becoming the norm, this integration positions them as a leader in travel tech. Plus, it’s a win for crypto enthusiasts who can now use their digital assets for real-world experiences. We love to see it!
$ARTL
Artelo Biosciences delivers hope for pain management.
$ARTL announced positive first-in-human data for ART26.12, a novel non-opioid treatment candidate for persistent pain.
Our take: This is a huge step forward in the fight against the opioid crisis. If ART26.12 continues to show promise, $ARTL could be a game-changer in the biopharma space. Fingers crossed for more good news!
$MNTS
Momentus takes a giant leap for space innovation.
$MNTS has won a contract in the highly competitive U.S. Space Force SpaceWERX Sustained Space Maneuver Challenge.
Our take: Space is the final frontier, and $MNTS is making its mark. Winning this contract is a testament to their capabilities and potential in the space tech industry. The stars seem to be aligning for Momentus—literally!
$BMNR
Bitmine bets big on Ethereum.
$BMNR announced a $250M private placement to advance its Ethereum treasury strategy.
Our take: This is a bold move that underscores $BMNR’s confidence in Ethereum’s future. With the crypto market’s volatility, this strategy could either pay off big or face challenges. Either way, it’s a fascinating play to watch.
$APDN
Applied DNA doubles down on synthetic DNA.
$APDN is sharpening its focus on synthetic DNA manufacturing for biotherapeutics applications and consolidating operations behind LineaRx.
Our take: Synthetic DNA is a niche but rapidly growing field, and $APDN’s strategic focus could position them as a leader. This is one to watch for biotech enthusiasts.
$PWM
Prestige Wealth pivots to tech-driven innovation.
$PWM has sold its asset management business to focus on technology-driven innovation in wealth management.
Our take: This is a smart move by $PWM. By shedding non-core operations, they’re doubling down on what they do best. It’s a bold pivot, but one that could pay off in the long run.
Today’s updates highlight the resilience and innovation driving these companies forward. Whether it’s embracing crypto, advancing biotech, or conquering space, there’s no shortage of ambition in the market.
That’s it for today, Stock Region fam! Which of these stories has you the most excited? Let us know, and as always, happy investing!
Disclaimer: The information provided in this newsletter is for educational and informational purposes only and does not constitute financial advice. Always consult with a financial advisor before making investment decisions.